Childhood hypertension: Current medical management;Prise en charge pharmacologique de l'hypertension artérielle chronique chez l'enfant: KISS, please

Revue Medicale Suisse

Volumn 1, Issue 19, 2005, Pages 1307-1310

  Simonetti, Giacomo D ^b   Fossali, Emilio ^c   Ramelli, Gian Paolo ^a   Bianchetti, Mario G ^a,c  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

^b Universitats Kinderklinik   (Switzerland)

^c Clinica Pediatrica De Marchi   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD PRESSURE; CHILDHOOD; DIABETES MELLITUS; HUMAN; HYPERTENSION; KIDNEY DISEASE; PEDIATRICIAN; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; CHILD;

ANTIHYPERTENSIVE AGENTS; CHILD; HUMANS; HYPERTENSION;

EID: 22844433402     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. von Vigier RO, Bianchetti MG. Arterielle Hypertonie im Kindes- und Adoleszentenalter. Ther Umsch 1999;56;12-8.
2. European Society of Hypertension - European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53
3. (Errata in: J Hypertens 2003;21:2203-4
4. and J Hypertens 2004;22: 435).
5. Whitworth JA. World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
6. Chobanian AV, Bakris GL, Black HR, et al. National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high blood pressure; national high blood pressure education program coordinating committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003;289: 2560-72
7. (Erratum in: JAMA 2003;290:197).
8. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society. Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004;18:139-85.
9. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43 (Suppl. 1):1-290.
10. Bianchetti MG, Caflisch M, Oetliker OH. Cough and converting enzyme inhibitors. Eur J Pediatr 1992;151: 225-6.
11. Pfammatter JP, Clericetti-Affolter C, Truttmann AC, et al. Amlodipine once-daily in systemic hypertension. Eur J Pediatr 1998;157:618-21.
12. von Vigier RO, Zberg PM, Teuffel O, Bianchetti MG. Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease. Eur J Pediatr 2000;159:590-3.
13. von Vigier RO, Mozzettini S, Truttmann AC, et al. Cough is common in children prescribed converting enzyme inhibitors. Nephron 2000;84:98.
14. von Vigier RO, Franscini LMD, Bianda NDF, et al. Antihypertensive efficacy of amlodipine in children with chronic kidney diseases. J Hum Hypertens 2001;15:387-91.
15. Franscini LMD, von Vigier RO, Pfister R, et al. Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases. Am J Hypertens 2002;15:1057-63.
16. Gartenmann AC, Fossali E, von Vigier RO, et al. Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium-channel blocker in childhood. Kidney Int 2003;64:1450-4.
17. Sieber US, von Vigier RO, Sforzini C, et al. How good is blood pressure control among treated hypertensive children and adolescents? J Hypertens 2003;21:633-7.
18. Ardissino G, Bianchetti MG, Braga M, et al. Raccomandazioni sull'ipertensione arteriosa in età pediatrica: il Progetto CHIld. Ital Heart J 2004;5:398-412.
19. Bianchetti MG, Ardissino G, Fossali E, Ramelli GP, Salice P. Tips for the use of antihypertensive drugs: DELTAREPROSI. J Pediatr 2004;145:288-90.
20. Calvetta A, Martino S, von Vigier RO, et al. What goes up must immediately come down! Which indication for short-acting nifedipine in children with arterial hypertension? Pediatr Nephrol 2003;18:1-2.
21. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-76.
22. Somu S, Sundaram B, Kamalanathan AN. Early detection of hypertension in general practice. Arch Dis Child 2003;88:302.
23. Bianchetti MG, Ardissino G, Fossali E, Ghiglia S, Pollini I, Salice O: CHIld project.A simple definition for normal, high-normal and high blood pressure in children and adolescents. J Hypertens 2004;22:2227-8.
24. Hilgers KF, Dötsch J, Rascher W, Mann JF. Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? Pediatr Nephrol 2004;19:956-61.
25. Brown MJ, Cruickshank JK, Dominiczak AF, et al. Executive Committee, British Hypertension Society. Better blood pressure control: how to combine drugs. J Hum Hypertens 2003;17:81-6.